(Total Views: 120)
Posted On: 10/13/2025 2:01:14 PM
Post# of 27513
BriaCell $BCTX shares positive Phase 3 biomarker data for Bria-IMT in metastatic breast cancer. Patients showing immune response had longer progression-free survival, with no new safety issues. Data to be presented at ESMO 2025: https://globenewswire.com/news-release/2025/1...-2025.html
(0)
(0)
